LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 1,421 pages found matching black box- Raptiva: An Itch That Can Kill
Feb-21-09 Washington, DC The road for a drug aimed at the treatment of psoriasis got a little rockier on Thursday after it was revealed the US Food and Drug Administration (FDA) has put Raptiva under the microscope after the drug was potentially linked to 3 deaths . In 2008 a black box warning was ordered. Two days ago the FDA revealed in a statement, "appropriat... - How Long to Heal after taking Levaquin?
Nov-6-08 Mount Vernon IL: Jackie W. had bladder surgery 6 years ago and her doctor prescribed Levaquin , a strong antibiotic, to prevent any infection. She has been suffering ever since; not from an infection but a painful shoulder separation, also known as Acromioclavicular (AC) joint sprain. "Just two days after I was on Levaquin I couldn't move my left arm... - Levaquin: Potential Tendon Problems a Serious Limitation
Aug-20-08 Titusville, NJ The problem with a drug prescribed for one malady, yet having a serious side effect impacting a totally different part of the body, is the surprise with which the occurrence often happens. Such is the case with Levaquin , an antibiotic used to treat infections—and its relationship to tendonitis and ruptured tendons . So what's the bi... - Levaquin Upgraded to Black Box Warning
Jul-12-08 Washington, DC On July 8, 2008 the FDA announced that Levaquin will get a black box warning on all fluoroquinolone antibiotics because of an increased risk for tendonitis and tendon rupture. The consumer group Public Citizen first petitioned the agency and then sued to get the warning issued. Levaquin (also known as levofloxacin) is a synthetic antib... - Lawsuit Against GSK Alleges Avandia To Blame For Injury Requiring Heart Bypass Surgery
Feb-13-08 Philadelphia, PA: Pat Kelly and his wife Sandra Kelly of Grove, Oklahoma, filed a lawsuit on February 12, 2008, against Philadelphia-based GlaxoSmithKline ("GSK"), the maker of Avandia , in the U.S. District Court for the Eastern District of Pennsylvania - Case 2:08-cv-00667-RK, accusing GSK of causing serious injury to Mr. Kelly due to its negligence, fr... - Lawmakers Catch Glaxo Hiding Paxil Suicide Risks - Again (Part II)
Feb-13-08 Washington, DC Apparently, GlaxoSmithKline is still trying to hide damaging information about Paxil, because 9 pages of a report released from under a court order last month, are not available to the public. However, Senator Charles Grassley has instructed Glaxo to provide him with the full report by February 14, 2008. In the report, which is dated roug... - $128,500 payout in racial harassment lawsuit.
Mentor, OH: (Dec-11-07) The city of Mentor brought charges against Michael McDonald, a 16-year-old Mentor boy, after he was found to have left a racist note at the home of a black family. The charges stemmed from McDonald leaving a box marked with the letters "KKK" in the driveway of Sylvia Spikes, who had just moved into the predominantly white neighborho... - Nurse's Family Files Avandia Wrongful Death Lawsuit against GlaxoSmithKline
Dec-18-07 San Diego, CA Rogelio Larosa and his adult son, Eric, of National City, San Diego County, California, filed a lawsuit on Monday, December 17, 2007, against Philadelphia-based GlaxoSmithKline ("GSK"), the maker of Avandia (rosiglitazone maleate), in U.S. District Court, Southern District of California (San Diego) accusing GSK of causing the wrongful death o... - Avandia: Yet Another Nail in the Coffin
Dec-12-07 Toronto, ON: A Canadian study, released yesterday, suggests that for every 100 people taking diabetes drug Avandia over a four-year period—five will die, four will suffer a heart attack and three more will experience heart failure. In response, the US Food and Drug Administration (FDA) is standing pat. The study, originating at the Institute for... - Avandia Dumped From Two Major Formularies
Dec-10-07 Eagan, MN A further sign that a diabetes drug linked to heart attack and heart failure is in trouble, was the news yesterday that two major drug benefit plans in the US have pulled Avandia from their formularies. Scores of physicians have recalled their patients from Avandia in recent months, and sales have been plummeting. Prime Therapeutics, whi... - Microsoft antitrust Settlement
The antitrust settlement between Microsoft and the Computer and Communications Industry Association resulted in a $9.75M payment to the CCIA top official. Ed Black, CCIA president, received almost half of the $19.75M payment. Ed Black's payment was approved by the CCIA board, which includes Sun Microsystems, Yahoo and Oracle. The CCIA board agreed the one... - Glaxo now faces Lawsuit by Shareholders over Avandia Problems
Jun-16-07 New York, NY GlaxoSmithKline PLC, the maker of the popular diabetes drug Avandia, just can't stay out of the news. And the news is all bad. Since May 21, when a meta-analysis (that is, an analysis of pooled data) of 42 clinical trials involving nearly 28,000 diabetes patients was published, showing that those taking Avandia had a 43% higher risk of... - Fireworks on Capitol Hill: FDA on the Defensive, Avandia Warnings Toughened
Jun-7-07 Washington, DC In an obvious attempt to save face, the U.S. Food and Drug Administration (FDA) yesterday announced severely toughened black box warnings for Avandia , and Actos - two diabetes drugs strongly suspected of increasing the risk of heart attack. In front of a packed Congressional hearing yesterday called to investigate the long delays by reg... - Doctors Ignore Black Box Warnings On SSRIs
Apr-2-07 Washington, DC: The FDA has issued numerous public health advisories and black box warnings over the past several years about the increased risk of suicidality associated with selective serotonin reuptake inhibitor antidepressants, but many doctors ignore them. In October 2004, the FDA added a black box warning about an increased risk of suicidality i... - FDA Strengthens Warnings on Xolair
Mar-2-07 Seattle, WA: The U.S. Food and Drug Administration (FDA) has called for a black box warning label for Xolair after receiving reports of serious allergic reactions to the drug. The alert was given after the FDA learned of 48 instances of anaphylactic shock that occurred between June, 2003 and December, 2005. Xolair was approved by the FDA for use in 20... - A Recall That Took Some Resistance
Jan-25-16 Washington, DC: Resistance cords continue to be an attractive method of resistance training for consumers who don’t have access to a gym or for whom using weights for resistance is an unrealistic option. Resistance cords and bands are also used in treatment protocols within physiotherapy. However, as innocent as resistance cords and bands appear when... - Novartis failed to Warn about Elidel Cancer Link
Dec-28-06 Washington, DC: Most lawsuits in which drug makers have tried to use preemption to dismiss failure-to-warn claims have been against companies accused of failing to warn about the risk of suicide associated with antidepressants known as selective serotonin inhibitors or SSRIs. However, a case in Pennsylvania against Novartis, involves a toddler who devel... - Drug Makers Trolling for Infants and Toddlers
Dec-21-06 The motive behind Big Pharma's promotion of the off-label prescribing of psychotropic drugs is market expansion and unfortunately, it just so happens that children provide the richest harvest because most kids are covered by health insurance plans or Medicaid. The various recruitment schemes include trolling for customers among infants and toddlers betwee... - No Excuse for marketing Ace Inhibitors to Pregnant Women
Oct-20-06 Waltham, MA In the wake of a study published in June 2006, in The New England Journal of Medicine found a higher rate of birth defects in infants born to mothers who filled prescriptions for Angiotensin-Converting Enzyme Inhibitors (ACE inhibitors), during the first trimester of pregnancy. The FDA advised women to reconsider the use of those drugs b... - Depo Provera lawsuit
Dec-29-05 Four women in Canada have filed a class action lawsuit against Pfizer Canada and Pfizer Inc. seeking relief of general damages for the sum of $500,000,000. The plaintiffs have all been long-term users of Depo-Provera, an injectable method of birth control, and they have all been diagnosed with bone mass density (BMS) problems including fractures, hip and spi...